Supplementary Figure S3 from A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan
Nakamura Y., Kaneva K., Lo C., Neems D., Freaney JE., Boulos H., Hyun SW., Islam F., Yamada-Hanff J., Driessen TM., Sonnenschein A., DeSantis DF., Kotani D., Watanabe J., Kotaka M., Mishima S., Bando H., Yamazaki K., Taniguchi H., Takemasa I., Kato T., Sangli C., Tell R., Blidner R., Yoshino T., Sasser K., Oki E., Nimeiri H.
<p>Figure S3. Site of clinical recurrence in longitudinal study</p>

